DrugPatentWatch Database Preview
Fluphenazine hydrochloride - Generic Drug Details
What are the generic sources for fluphenazine hydrochloride and what is the scope of freedom to operate?
Fluphenazine hydrochloride
is the generic ingredient in three branded drugs marketed by Ani Pharms Inc, Pharm Assoc, Schering, Apothecon, Fresenius Kabi Usa, Lannett Co Inc, Mylan, Sandoz, and Watson Labs, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.There are nineteen drug master file entries for fluphenazine hydrochloride. Eight suppliers are listed for this compound.
Summary for fluphenazine hydrochloride
| US Patents: | 0 |
| Tradenames: | 3 |
| Applicants: | 9 |
| NDAs: | 18 |
| Drug Master File Entries: | 19 |
| Suppliers / Packagers: | 8 |
| Bulk Api Vendors: | 56 |
| Clinical Trials: | 9 |
| Patent Applications: | 2,326 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | fluphenazine hydrochloride at DailyMed |
Recent Clinical Trials for fluphenazine hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Canadian Network for Observational Drug Effect Studies, CNODES | N/A |
| Canadian Institutes of Health Research (CIHR) | N/A |
| Drug Safety and Effectiveness Network, Canada | N/A |
Pharmacology for fluphenazine hydrochloride
| Drug Class | Phenothiazine |
US Patents and Regulatory Information for fluphenazine hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | FLUPHENAZINE HYDROCHLORIDE | fluphenazine hydrochloride | TABLET;ORAL | 089586-003 | Oct 16, 1987 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Mylan | FLUPHENAZINE HYDROCHLORIDE | fluphenazine hydrochloride | TABLET;ORAL | 089804-003 | Aug 12, 1988 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Lannett Co Inc | FLUPHENAZINE HYDROCHLORIDE | fluphenazine hydrochloride | TABLET;ORAL | 089743-004 | Aug 25, 1988 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2020 - 2021
NCE-1 Patent Challenge Dates 2020 - 2021
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2020, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
